MIR4521: A Drug Target / Disease Biomarker (G100616406)
MIR4521: A Drug Target / Disease Biomarker
MIR4521 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the Mir gene family, which encodes for a family of transmembrane proteins that play important roles in various physiological processes. One of the functions of MIR4521 is to regulate the levels of glucose in the body.
MIR4521 is a key regulator of the hepatic glucose output pathway, which is responsible for shipping glucose from the liver to the rest of the body. MIR4521 is a critical protein that helps to ensure that the liver produces and releases the correct amount of glucose to keep the body's blood sugar levels within a healthy range.
MIR4521 is also involved in the regulation of other physiological processes that are important for the body, including cell signaling, inflammation, and stress response. It is a key regulator of the production of adenosine, a molecule that plays a critical role in the body's stress response.
MIR4521 is also a potential drug target for several diseases, including diabetes, heart disease, and neurodegenerative diseases. Its role in the regulation of glucose and adenosine production makes it an attractive target for interventions aimed at treating these diseases.
One of the ways that MIR4521 is being targeted for drug development is through its role in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. These conditions are characterized by the progressive loss of brain cells and the development of neurofibrillary tangles, which are thought to be a hallmark of the disease.
MIR4521 is thought to be involved in the development of neurodegenerative diseases because it is expressed in the brain and is involved in the regulation of important cellular processes that are involved in the development and progression of these conditions. For example, studies have shown that MIR4521 is involved in the production of neurofibrillary tangles, which are a hallmark of Alzheimer's disease.
In addition to its role in the development of neurodegenerative diseases, MIR4521 is also being targeted for drug development due to its role in the regulation of glucose and adenosine production. conditions, such as diabetes and heart disease.
MIR4521 is an attractive target for drug development because it is involved in the regulation of important cellular processes that are involved in the development and progression of a wide range of diseases. Its role in the regulation of glucose and adenosine production makes it an attractive target for interventions aimed at treating these diseases.
Protein Name: MicroRNA 4521
More Common Targets
MIR4524A | MIR4524B | MIR4525 | MIR4526 | MIR4527 | MIR4527HG | MIR4529 | MIR4530 | MIR4531 | MIR4533 | MIR4534 | MIR4535 | MIR4536-1 | MIR4536-2 | MIR4537 | MIR4538 | MIR4539 | MIR454 | MIR4540 | MIR455 | MIR4632 | MIR4633 | MIR4634 | MIR4635 | MIR4638 | MIR4639 | MIR4640 | MIR4641 | MIR4642 | MIR4644 | MIR4645 | MIR4646 | MIR4647 | MIR4648 | MIR4649 | MIR4650-1 | MIR4650-2 | MIR4651 | MIR4652 | MIR4653 | MIR4655 | MIR4656 | MIR4657 | MIR4658 | MIR4659A | MIR4659B | MIR466 | MIR4660 | MIR4661 | MIR4662A | MIR4663 | MIR4664 | MIR4665 | MIR4666A | MIR4666B | MIR4667 | MIR4668 | MIR4669 | MIR4670 | MIR4671 | MIR4672 | MIR4673 | MIR4674 | MIR4675 | MIR4676 | MIR4677 | MIR4679-1 | MIR4679-2 | MIR4680 | MIR4681 | MIR4684 | MIR4685 | MIR4686 | MIR4687 | MIR4688 | MIR4689 | MIR4690 | MIR4691 | MIR4692 | MIR4693 | MIR4694 | MIR4695 | MIR4697 | MIR4697 host gene (non-protein coding) | MIR4698 | MIR4699 | MIR4700 | MIR4701 | MIR4703 | MIR4704 | MIR4706 | MIR4707 | MIR4708 | MIR4709 | MIR4711 | MIR4712 | MIR4713 | MIR4713HG | MIR4714 | MIR4715
